2,635 Shares in Colgate-Palmolive (NYSE:CL) Acquired by Mountain Pacific Investment Advisers Inc. ID

Mountain Pacific Investment Advisers Inc. ID bought a new position in shares of Colgate-Palmolive (NYSE:CL) in the fourth quarter, HoldingsChannel reports. The firm bought 2,635 shares of the company’s stock, valued at approximately $210,000.

A number of other large investors have also bought and sold shares of the business. OFI Invest Asset Management acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $25,000. Avion Wealth boosted its holdings in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after buying an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $34,000. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in shares of Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after buying an additional 291 shares during the last quarter. Finally, West Branch Capital LLC boosted its holdings in shares of Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after buying an additional 132 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CL shares. UBS Group raised their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a report on Monday, January 29th. Evercore ISI raised their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Barclays raised their price target on Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a report on Thursday, January 18th. Finally, Stifel Nicolaus increased their price objective on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Price Performance

Shares of NYSE CL traded up $1.72 during mid-day trading on Friday, reaching $91.01. The company had a trading volume of 7,541,541 shares, compared to its average volume of 3,968,951. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. Colgate-Palmolive has a one year low of $67.62 and a one year high of $92.25. The firm has a market cap of $74.81 billion, a price-to-earnings ratio of 32.74, a PEG ratio of 3.35 and a beta of 0.42. The business’s 50-day simple moving average is $87.66 and its 200 day simple moving average is $81.46.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the firm posted $0.73 earnings per share. Colgate-Palmolive’s revenue was up 6.2% compared to the same quarter last year. On average, research analysts predict that Colgate-Palmolive will post 3.5 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 71.94%.

Insider Activity

In other news, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the sale, the director now directly owns 19,272 shares of the company’s stock, valued at $1,628,484. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total value of $233,220.00. Following the transaction, the director now directly owns 19,272 shares of the company’s stock, valued at $1,628,484. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Noel R. Wallace sold 29,772 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $84.06, for a total value of $2,502,634.32. Following the completion of the transaction, the chief executive officer now directly owns 301,343 shares in the company, valued at $25,330,892.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock valued at $19,505,099. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.